A comparative study on pharmacokinetics and tissue distribution of 5-hydroxy-4-methoxycanthin-6-one and its metabolite in normal and dextran sodium sulfate-induced colitis rats by HPLC-MS/MS
- 3 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 72 (12), 1761-1770
- https://doi.org/10.1111/jphp.13285
Abstract
Objectives This study aimed to investigate the existing form of 5‐hydroxy‐4‐methoxycanthin‐6‐one (PQ‐A) in vivo after oral administration and the effects on its pharmacokinetics and tissue distribution by colitis. Methods A rapid HPLC‐MS/MS method was established to simultaneously determine PQ‐A and its main metabolite, 1‐methoxicabony‐β‐carboline (PQ‐B), in biological samples acquired from normal and dextran sodium sulfate (DSS)‐induced colitic rats administered orally with PQ‐A. Then, the pharmacokinetics of both PQ‐A and PQ‐B, and tissue distribution of PQ‐A in the above two states were analysed. Key findings The pharmacokinetic results showed that the prototype of PQ‐A was the main existing form in both physiological and pathological conditions. And significant difference between the above two status in pharmacokinetics of PQ‐A was observed, such as higher exposure and longer elimination in colitis than that in normal rats. It suggested that the pharmacokinetics of medications for colitis was affected by enteritis. The tissue distribution studies displayed that PQ‐A mainly accumulated in intestinal tract. Especially, the distribution of PQ‐A in intestinal tract was increased obviously in colitic rats. Conclusions These results contributed to further illuminate the ADME process of PQ‐A in different status and were prospected to be the reference to the clinical application of similar medicines in pathological states.Keywords
Funding Information
- National Natural Science Foundation of China (81573566, 81673872, 81773969, 81873091, 81974520)
- Guangzhou University of Chinese Medicine (The grants for Major Research Projects for the Tra)
This publication has 25 references indexed in Scilit:
- Identification of in vivo and in vitro metabolites of 4,5-dimethoxycanthin-6-one by HPLC–Q-TOF-MS/MSJournal of Chromatography B, 2016
- A Review on Chemical-Induced Inflammatory Bowel Disease Models in RodentsKorean Journal of Physiology & Pharmacology, 2014
- Comparative Pharmacokinetic Study of Chlorogenic Acid after Oral Administration of Lonicerae Japonicae Flos and Shuang‐Huang‐Lian in Normal and Febrile RatsPhytotherapy Research, 2013
- In vitro and in vivo anti-inflammatory effects of 4-methoxy-5- hydroxycanthin-6-one, a natural alkaloid from Picrasma quassioidesPhytomedicine, 2013
- Increased small intestinal permeability in ulcerative colitis: Rather genetic than environmental and a risk factor for extensive disease?Inflammatory Bowel Diseases, 2012
- Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug responseExpert Review of Clinical Pharmacology, 2012
- Cytotoxic Alkaloids from the Wood of Picrasma quassioidesJournal of the Korean Society for Applied Biological Chemistry, 2009
- Protective Effect of 4-Methoxy-5-hydroxycanthin-6-one, A Natural Alkaloid, on Dextran Sulfate Sodium-Induced Rat ColitisPlanta Medica, 2008
- Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloidsBioorganic & Medicinal Chemistry, 2004
- Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cellsJournal of Pharmaceutical Sciences, 2001